Development of Alzheimer’s Disease Biomarkers: From CSF- to Blood-Based Biomarkers

In the 115 years since the discovery of Alzheimer’s disease (AD), our knowledge, diagnosis, and therapeutics have significantly improved. Biomarkers are the primary tools for clinical research, diagnostics, and therapeutic monitoring in clinical trials. They provide much insightful information, and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Sakulrat Mankhong, Sujin Kim, Seongju Lee, Hyo-Bum Kwak, Dong-Ho Park, Kyung-Lim Joa, Ju-Hee Kang
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI AG 2022-04-01
Colecção:Biomedicines
Assuntos:
Alzheimer’s biomarker
cerebrospinal fluid
blood-based biomarker
clinical trial
amyloid-beta
tau
Acesso em linha:https://www.mdpi.com/2227-9059/10/4/850
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados